亚裔美国成年人的癌症命运主义根据原产地组,2012-2022年
Justine Liu1, Yenan Zhu2, Ryan Suk3,4,5
1Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Cancer medicine
|March 18, 2025
概括
癌症命运主义在亚洲起源群体之间有所不同. 与越南和菲律宾人相比,印度受访者对宿命主义的信仰较低,这凸显了针对癌症预防策略的需求.
科学领域:
- 公共卫生 公共卫生
- 癌症预防研究 癌症预防研究
- 健康差异 在健康上的差异
背景情况:
- 癌症宿命主义,即认为癌症是预先确定的,无法预防的信念,与减少癌症预防行为有关.
- 在不同亚洲族群中,癌症宿命主义的流行程度仍未得到充分研究.
研究的目的:
- 分析不同亚洲起源群体中癌症宿命主义的流行情况.
- 在中国,菲律宾,印度和越南人群中发现癌症命运主义信仰的显著差异.
主要方法:
- 利用了2012-2022年健康信息国家趋势调查的分类数据.
- 进行了双对比,以评估特定亚洲族群之间癌症宿命论认可的差异.
主要成果:
- 与越南人 (74.59%) 和菲律宾人 (75.18%) 相比,印度受访者 (40.36%) 相信"一切都会导致癌症"的可能性明显低.
- 虽然在统计学上并不显著,但印度和中国的受访者报告说,他们比越南和菲律宾的受访者更少支持"你不能做太多的事情来降低患癌症的机会".
结论:
- 在亚洲人群中,癌症命运主义信仰中表现出显著的异质性.
- 强调需要分类数据收集和文化特定干预措施,以有效解决癌症宿命论的关键需求.
相关概念视频
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Actuarial Approach
50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


